Serum CGRP in migraine patients using erenumab as preventive treatment

Aim Serum levels of Calcitonin Gene-Related Peptide (CGRP)-like immunoreactivity (CGRP-LI) in migraine patients before and after starting treatment with erenumab were measured to evaluate the association with clinical treatment response. Methods Blood samples were collected from the cubital fossa be...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of headache and pain Vol. 23; no. 1; pp. 120 - 7
Main Authors:	de Vries Lentsch, Simone, Garrelds, Ingrid M., Danser, A. H. Jan, Terwindt, Gisela M., MaassenVanDenBrink, Antoinette
Format:	Journal Article
Language:	English
Published:	Milan Springer Milan 01.12.2022 Springer Nature B.V BMC
Subjects:	Calcitonin Calcitonin gene-related peptide CGRP Headache Immunoreactivity Internal Medicine Medicine Medicine & Public Health Migraine Monoclonal antibodies Neurology Pain Medicine Patients Peptides Radioimmunoassay Regression analysis Serum Serum levels Monoclonal antibodies Serum CGRP Migraine
ISSN:	1129-2369, 1129-2377, 1129-2377
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!